Over half of HFmrEF/HFpEF participants had CHD, with baseline differences including sex, diabetes, peripheral arterial disease, biomarker profiles, and greater use of antithrombotic therapies. CHD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results